271 related articles for article (PubMed ID: 26746169)
41. Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn's Disease: A Systematic Review and Meta-Analysis.
Sharma T; Ma C; Sedano R; Hanzel J; McDonald C; Hogan M; Kochhar GS; Narula N; Peyrin-Biroulet L; Danese S; MacDonald JK; Jairath V
J Crohns Colitis; 2023 Apr; 17(4):644-658. PubMed ID: 36271904
[TBL] [Abstract][Full Text] [Related]
42. Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice.
van Gennep S; de Boer NK; D'Haens GR; Löwenberg M
Inflamm Bowel Dis; 2017 Dec; 24(1):67-77. PubMed ID: 29272488
[TBL] [Abstract][Full Text] [Related]
43. Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis.
Kornbluth AA; Salomon P; Sacks HS; Mitty R; Janowitz HD
J Clin Gastroenterol; 1993 Apr; 16(3):215-8. PubMed ID: 8099363
[TBL] [Abstract][Full Text] [Related]
44. Meta-analysis of the placebo response in ulcerative colitis.
Garud S; Brown A; Cheifetz A; Levitan EB; Kelly CP
Dig Dis Sci; 2008 Apr; 53(4):875-91. PubMed ID: 17934839
[TBL] [Abstract][Full Text] [Related]
45. EFFICACY OF TACROLIMUS FOR INDUCTION OF REMISSION IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Lasa J; Olivera P
Arq Gastroenterol; 2017; 54(2):167-172. PubMed ID: 28327826
[TBL] [Abstract][Full Text] [Related]
46. Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis.
Gisbert JP; Linares PM; McNicholl AG; Maté J; Gomollón F
Aliment Pharmacol Ther; 2009 Jul; 30(2):126-37. PubMed ID: 19392869
[TBL] [Abstract][Full Text] [Related]
47. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Marshall JK; Thabane M; Steinhart AH; Newman JR; Anand A; Irvine EJ
Cochrane Database Syst Rev; 2010 Jan; (1):CD004115. PubMed ID: 20091560
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
Ford AC; Sandborn WJ; Khan KJ; Hanauer SB; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):644-59, quiz 660. PubMed ID: 21407183
[TBL] [Abstract][Full Text] [Related]
49. Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease.
Ma C; Lee JK; Mitra AR; Teriaky A; Choudhary D; Nguyen TM; Vande Casteele N; Khanna R; Panaccione R; Feagan BG; Jairath V
Aliment Pharmacol Ther; 2019 Jul; 50(1):5-23. PubMed ID: 31119766
[TBL] [Abstract][Full Text] [Related]
50. Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis.
Feagan BG; Sandborn WJ; Lazar A; Thakkar RB; Huang B; Reilly N; Chen N; Yang M; Skup M; Mulani P; Chao J
Gastroenterology; 2014 Jan; 146(1):110-118.e3. PubMed ID: 24067881
[TBL] [Abstract][Full Text] [Related]
51. Corticosteroid-Free Remission vs Overall Remission in Clinical Trials of Moderate-Severe Ulcerative Colitis and Crohn's Disease.
George J; Singh S; Dulai PS; Ma C; Nguyen T; Feagan BG; Sandborn WJ; Jairath V
Inflamm Bowel Dis; 2020 Mar; 26(4):515-523. PubMed ID: 31504528
[TBL] [Abstract][Full Text] [Related]
52. Effect of antibiotic therapy in patients with ulcerative colitis: a meta-analysis of randomized controlled trials.
Xi W; Li Z; Ren R; Sai XY; Peng L; Yang Y
Scand J Gastroenterol; 2021 Feb; 56(2):162-170. PubMed ID: 33307882
[TBL] [Abstract][Full Text] [Related]
53. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
Khan KJ; Dubinsky MC; Ford AC; Ullman TA; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):630-42. PubMed ID: 21407186
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and Safety of Tacrolimus Therapy for Active Ulcerative Colitis; A Systematic Review and Meta-analysis.
Komaki Y; Komaki F; Ido A; Sakuraba A
J Crohns Colitis; 2016 Apr; 10(4):484-94. PubMed ID: 26645641
[TBL] [Abstract][Full Text] [Related]
56. Budesonide foam for mild to moderate distal ulcerative colitis: A systematic review and meta-analysis.
Zeng J; Lv L; Mei ZC
J Gastroenterol Hepatol; 2017 Mar; 32(3):558-566. PubMed ID: 27699863
[TBL] [Abstract][Full Text] [Related]
57. One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2.
Sandborn WJ; Colombel JF; D'Haens G; Van Assche G; Wolf D; Kron M; Lazar A; Robinson AM; Yang M; Chao JD; Thakkar R
Aliment Pharmacol Ther; 2013 Jan; 37(2):204-13. PubMed ID: 23173821
[TBL] [Abstract][Full Text] [Related]
58. Antibiotics for induction and maintenance of remission in ulcerative colitis: systematic review and meta-analysis.
Mishra S; Jha DK; Singh AK; Kumar-M P; Patil A; Sharma V
Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1215-1223. PubMed ID: 33827360
[No Abstract] [Full Text] [Related]
59. Infliximab is superior to other biological agents for treatment of active ulcerative colitis: A meta-analysis.
Mei WQ; Hu HZ; Liu Y; Li ZC; Wang WG
World J Gastroenterol; 2015 May; 21(19):6044-51. PubMed ID: 26019471
[TBL] [Abstract][Full Text] [Related]
60. [A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis].
Ohno K; Masunaga Y; Ogawa R; Hashiguchi M; Ogata H
Yakugaku Zasshi; 2004 Aug; 124(8):555-60. PubMed ID: 15297725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]